Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-01-24

Clinical Trial Update: Minocycline for Alcohol Use Disorder [Phase 1, Phase 2]

View source ↗

Summary

A UCLA-sponsored clinical trial evaluating minocycline for alcohol use disorder has been withdrawn from Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Alcohol Use Disorder, Inflammation | Phase 1, Phase 2 | Status: WITHDRAWN